This study is a prospective, single-arm study conducted under a common implant and follow-up protocol. The objective will be to follow fifty-seven (57) adolescents and young adults (10-21 years of age), with Down syndrome, moderate to severe sleep apnea, and post-adenotonsillectomy, for 12 months after undergoing implant of the Inspire Upper Airway Stimulation (UAS) System. The study is being conducted in order to evaluate objective change in cognition and expressive language after implant and therapy with the Inspire UAS System.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in intelligence using the Kaufman Brief Intelligence Scale (KBIT-2)
Timeframe: 6 Months post-implant
Change in attention using the Wechsler Intelligence Scale
Timeframe: 6 Months post-implant
Change in processing speed using the Cambridge Neuropsychological Test Automated Battery (CANTAB)
Timeframe: 6 Months post-implant
Change in executive functioning using the Delis-Kaplan Executive Functioning System (DKEFS)
Timeframe: 6 Months post-implant
Change in learning and memory using the Cambridge Neuropsychological Test Automated Battery - Paired Associates Learning
Timeframe: 6 Months post-implant
Change in language using Expressive Language Sampling
Timeframe: 6 Months post-implant